Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Social Science & Medicine (1982)|August 8, 2024
A novel approach for health state valuation: Multiple bounded dichotomous choice compared to the traditional standard gambleThomas G Poder, Hosein AmeriExpert Review of Pharmacoeconomics & Outcomes Research|March 6, 2026
Duration changes and decision-making in DCETTO: evidence from SF-6Dv2Hosein Ameri, Thomas G PoderHealth and Quality of Life Outcomes|November 4, 2025
Utility score mapping from FACT-G to EQ-5D-5L and SF-6Dv2 in breast and colorectal cancer patients: a focus on beta mixture modelsThomas G Poder, Hosein AmeriThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 28, 2024
Comparison of four approaches in eliciting health state utilities with SF-6Dv2Hosein Ameri, Thomas G PoderValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 18, 2026
Impact of Smoothing and Modeling Approach on Quality-Adjusted Life Expectancy EstimatesHosein Ameri, Thomas G PoderInternational Journal of Health Policy and Management|December 2, 2024
Valuing SF-6Dv2 Using a Discrete Choice Experiment in a General Population in Quebec, CanadaHosein Ameri, Thomas G PoderSocial Science & Medicine (1982)|December 25, 2024
A new SF-6Dv2 value set based on a hybrid model using SG, cTTO, and DCE dataThomas G Poder, Hosein AmeriSocial Science & Medicine (1982)|August 17, 2025
Comparison of methods for anchoring latent values on the full health-dead utility scaleThomas G Poder, Hosein AmeriBreast Cancer (Tokyo, Japan)|March 5, 2021
Psychometric properties of the SF-6Dv2 in an Iranian breast cancer populationAzin Nahvijou, Hossein Safari, Hosein AmeriExpert Review of Pharmacoeconomics & Outcomes Research|October 27, 2020
Exploring the consistency of the SF-6Dv2 in a breast cancer populationHosein Ameri, Hossein Safari, Thomas PoderPageof 4